Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly

Tohoku Journal of Experimental Medicine

Volumn 228, Issue 4, 2012, Pages 295-299

  Ito, Takeshi ^a   Akagi, Kentaro ^a   Kondo, Tadakazu ^a   Kawabata, Hiroshi ^a   Ichinohe, Tatsuo ^a,b   Takaori Kondo, Akifumi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Myelofibrosis; Myeloproliferative neoplasms; Reducedintensity conditioning regimen; Splenic irradiation

Indexed keywords

BUSULFAN; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; DISEASE SEVERITY; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MORBIDITY; MYELOID METAPLASIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REDUCED INTENSITY CONDITIONING; RISK REDUCTION; SPLENECTOMY; SPLENOMEGALY; SURGICAL RISK; THERAPY EFFECT; THROMBOCYTHEMIA; WHOLE BODY RADIATION;

DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRIMARY MYELOFIBROSIS; SPLEEN; SPLENOMEGALY; TRANSPLANTATION CONDITIONING;

EID: 84869078585     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.228.295     Document Type: Article

References (14)

1. Bacigalupo, A., Soraru, M., Dominietto, A., Pozzi, S., Geroldi, S., Van Lint, M.T., Ibatici, A., Raiola, A.M., Frassoni, F., De Stefano, F., Verdiani, S., Casarino, L. & Barosi, G. (2010) Allogeneic hemopoietic SCT for patients with primary myelo fibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant 45 458-463
2. Ballen, K.K., Shrestha, S., Sobocinski, K.A., Zhang, M.J., Bashey, A., Bolwell, B.J., Cervantes, F., Devine, S.M., Gale, R.P., Gupta, V., Hahn, T.E., Hogan, W.J., Kroger, N., Litzow, M.R., Marks, D.I., Maziarz, R.T., McCarthy, P.L., Schiller, G., Schouten, H.C., Roy, V., Wiernik, P.H., Horowitz, M.M., Giralt, S.A. & Arora, M. (2010) Outcome of transplantation for myelofibrosis. Biol. Blood Marrow Transplant., 16, 358-367.
3. Bouabdallah, R., Coso, D., Gonzague-Casabianca, L., Alzieu, C., Resbeut, M. & Gastaut, J.A. (2000) Safety and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients. Leuk. Res., 24, 491-495.
4. Cervantes, F., Dupriez, B., Pereira, A., Passamonti, F., Reilly, J.T., Morra, E., Vannucchi, A.M., Mesa, R.A., Demory, J.L., Barosi, G., Rumi, E. & Tefferi, A. (2009) New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood, 113, 2895-2901.
5. Elliott, M.A., Chen, M.G., Silverstein, M.N. & Tefferi, A. (1998) Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J. Haematol., 103, 505-511.
6. Gratwohl, A., Hermans, J., van Biezen, A., Arcese, W., Debusscher, L., Ernst, P., Ferrant, A., Frassoni, F., Gahrton, G., Iriondo, A., Kolb, H.J., Link, H., Niederwieser, D., Ruutu, T., Siegert, W. & Zwaan, F.E. (1996) Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J. Haematol., 95, 494-500.
7. Harrison, C., Kiladjian, J.J., Al-Ali, H.K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D.S., Levy, R., Knoops, L., Cervantes, F., Vannucchi, A.M., Barbui, T. & Barosi, G. (2012) JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N. Engl. J. Med., 366, 787-798.
8. Jabro, G., Koc, Y., Boyle, T., Schenkein, D.P., Ravalese, J., Wazer, D. & Miller, K.B. (1999) Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant., 5, 173-179.
9. Kroger, N., Holler, E., Kobbe, G., Bornhauser, M., Schwerdtfeger, R., Baurmann, H., Nagler, A., Bethge, W., Stelljes, M., Uharek, L., Wandt, H., Burchert, A., Corradini, P., Schubert, J., Kaufmann, M., Dreger, P., Wulf, G.G., Einsele, H., Zabelina, T., Kvasnicka, H.M., Thiele, J., Brand, R., Zander, A.R., Niederwieser, D. & de Witte, T.M. (2009) Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood, 114, 5264-5270.
10. Patriarca, F., Bacigalupo, A., Sperotto, A., Isola, M., Soldano, F., Bruno, B., van Lint, M.T., Iori, A.P., Santarone, S., Porretto, F., Pioltelli, P., Visani, G., lacopino, P., Fanin, R. & Bosi, A. (2008) Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Haematologica, 93, 1514-1522.
11. Robin, M., Tabrizi, R., Mohty, M., Furst, S., Michallet, M., Bay, J.O., Cahn, J.Y., De Coninck, E., Dhedin, N., Bernard, M., Rio, B., Buzyn, A., Huynh, A., Bilger, K., Bordigoni, P., Contentin, N., Porcher, R., Socie, G. & Milpied, N. (2011) Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC). Br. J. Haematol., 152, 331-339.
12. Stewart, W.A., Pearce, R., Kirkland, K.E., Bloor, A., Thomson, K., Apperley, J., McQuaker, G., Marks, D.I., Craddock, C., McCann, S., Russell, N., Cook, G. & Kottaridis, P.D. (2010) The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study. Bone Marrow Transplant., 45, 1587-1593.
13. Tefferi, A., Mesa, R.A., Nagorney, D.M., Schroeder, G. & Silver-stein, M.N. (2000) Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood, 95, 2226-2233.
14. Verstovsek, S., Mesa, R.A., Gotlib, J., Levy, R.S., Gupta, V., DiPersio, J.F., Catalano, J.V., Deininger, M., Miller, C., Silver, R.T., Talpaz, M., Winton, E.F., Harvey, J.H. Jr., Arcasoy, M.O., Hexner, E., Lyons, R.M., Paquette, R., Raza, A., Vaddi, K., Erickson-Viitanen, S., Koumenis, I.L., Sun, W., Sandor, V. & Kantarjian, H.M. (2012) A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N. Engl. J. Med., 366, 799-807.